Abstract:Background: The persistence of chemotherapy-resistant and dormant cancer cells remains a critical challenge in the treatment of lung cancer. Objectives: This review focuses on non-small cell lung cancer and small cell lung cancer, examining the complex mechanisms that drive treatment resistance. Methods: This review analyzed current studies on chemotherapy resistance in NSCLC and SCLC, focusing on tumor microenvironment, genetic mutations, cancer cell heterogeneity, and emerging therapies. Results: Conventional chemotherapy and targeted therapies, such as tyrosine kinase inhibitors, often fail due to factors including the tumor microenvironment, genetic mutations, and cancer cell heterogeneity. Dormant cancer cells, which can remain undetected in a quiescent state for extended periods, pose a significant risk of recurrence upon reactivation. These cells, along with intrinsic resistance mechanisms, greatly complicate treatment efforts. Understanding these pathways is crucial for the development of more effective therapies. Emerging strategies, including combination therapies that target multiple pathways, are under investigation to improve treatment outcomes. Innovative approaches, such as antibody–drug conjugates and targeted protein degradation, offer promising solutions by directly delivering cytotoxic agents to cancer cells or degrading proteins that are essential for cancer survival. The lung cancer organoid model shows substantial promise to advance both research and clinical applications in this field, enhancing the ability to study resistance mechanisms and develop personalized treatments. The integration of current research underscores the need for continuous innovation in treatment modalities. Conclusions: Personalized strategies that combine novel therapies with an in-depth understanding of tumor biology are essential to overcome the challenges posed by treatment-resistant and dormant cancer cells in lung cancer. A multifaceted approach has the potential to significantly improve patient outcomes.

Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer

Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer

Molecular Mechanisms of Chemo‐ and Radiotherapy Resistance and the Potential Implications for Cancer Treatment

Review of possible mechanisms of radiotherapy resistance in cervical cancer

Molecular mechanisms of tumor resistance to radiotherapy

Recent Progress of the Tumor Microenvironmental Metabolism in Cervical Cancer Radioresistance

Empowering Radiotherapy: Harnessing Nanomedicines to Enhance Radiation Response and Boost Antitumor Efficacy

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer

Resistance To Radiotherapy In Lung Cancer

Myriad factors and pathways influencing tumor radiotherapy resistance

Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer

A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma

The Synergistic Effects of Traditional Chinese Herbs and Radiotherapy for Cancer Treatment

Mechanisms of Chemotherapeutic Resistance and the Application of Targeted Nanoparticles for Enhanced Chemotherapy in Colorectal Cancer

Radiation-induced Tumor Immune Microenvironments and Potential Targets for Combination Therapy

Cancer Stem Cells And Signaling Pathways In Radioresistance

Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

Navigating the Complexity of Resistance in Lung Cancer Therapy: Mechanisms, Organoid Models, and Strategies for Overcoming Treatment Failure

Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies

Role of Metabolism in Cancer Cell Radioresistance and Radiosensitization Methods